We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Eden Research plc (EDEN) Ordinary 1p

Sell:4.30p Buy:4.80p 0 Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:4.30p
Buy:4.80p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:4.30p
Buy:4.80p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Eden Research plc is a United Kingdom-based company, which is focused on biopesticides for sustainable agriculture. The Company develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products are formulated with terpene active ingredients, based on natural plant defense metabolites. Its product portfolio includes Mevalone and Cedroz. Mevalone is a foliar biofungicide, which targets a key disease affecting grapes and other high-value fruit and vegetable crops. Cedroz is a bionematicide that targets free-living nematodes, which are parasitic worms that affect a range of high-value fruit and vegetable crops globally. The Company's Sustaine encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease of use.

Contact details

Address:
67C Innovation Drive, Milton Park
OXFORD
OX14 4RQ
United Kingdom
Telephone:
+44 (01285) 359555
Website:
www.edenresearch.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 22 January 2024 22/01/24
Interim results 29 September 2023 29/09/23
General meeting 17 August 2023 17/08/23
AGM 29 June 2023 29/06/23
Annual report 07 June 2023 07/06/23
Final results 05 May 2023 05/05/23

General stock information

EPIC:
EDEN
ISIN:
GB0001646941
Market cap:
£24.27 million
Shares in issue:
533.35 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Sean Smith
    Chief Executive Officer, Executive Director
  • Alex Abrey
    Chief Financial Officer, Company Secretary, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.